Rockefeller Capital Management
VYGR icon

Rockefeller Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Rockefeller Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83K Sell
809
-418
-34% -$1.58K ﹤0.01% 4355
2026
Q1 		$4.74K Buy
1,227
+318
+35% +$1.25K ﹤0.01% 4263
2025
Q4 		$3.57K Buy
909
+159
+21% +$703 ﹤0.01% 4166
2025
Q3 		$3.5K Buy
+750
New +$2.71K ﹤0.01% 3977
2023
Q1 		– Sell
-650
Closed -$3K – 3855
2022
Q4 		$3K Hold
650
– – ﹤0.01% 3498
2022
Q3 		$3K Buy
650
+396
+156% +$2.54K ﹤0.01% 3520
2022
Q2 		$1K Buy
+254
New +$1.72K ﹤0.01% 4031
2020
Q2 		– Sell
-4,865
Closed -$45K – 2699
2020
Q1 		$45K Sell
4,865
-1,065
-18% -$12.2K ﹤0.01% 1274
2019
Q4 		$83K Sell
5,930
-82
-1% -$1.19K ﹤0.01% 1013
2019
Q3 		$103K Sell
6,012
-138
-2% -$2.9K ﹤0.01% 799
2019
Q2 		$167K Buy
+6,150
New +$141K ﹤0.01% 606

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Rockefeller Capital Management's VYGR Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Voyager Therapeutics (VYGR) stake by 34% in Q2 2026, selling an estimated $1.58K and leaving 809 shares worth $2.83K. The position accounts for ﹤0.01% of the portfolio, ranked #4355.

Rockefeller Capital Management first reported a position in VYGR in Q2 2019 and has held it in 11 quarters since. The position peaked at $167K in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Rockefeller Capital Management held 809 shares of Voyager Therapeutics worth $2.83K as of Q2 2026.
  • Rockefeller Capital Management sold 418 Voyager Therapeutics shares in Q2 2026, an estimated $1.58K.
  • Voyager Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4355 holding.
  • Rockefeller Capital Management first reported a position in Voyager Therapeutics in Q2 2019 and has held it in 11 quarters since.
  • Rockefeller Capital Management's Voyager Therapeutics position peaked at $167K in Q2 2019.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.